Tracking prions: the neurografting approach

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Transmissible spongiform encephalopathies (prion diseases) present significant enigmas regarding the infectious agent's nature, brain damage mechanisms, and central nervous system (CNS) affinity control.
• Investigating these complex diseases has been significantly advanced by transgenic and knockout technologies.

Purpose of the Study:

• To demonstrate how transgenic and knockout systems can effectively address key questions in prion disease pathogenesis.
• To elucidate the mechanisms of brain damage and the control of prion agent affinity for the CNS.
• To provide insights into prion access to CNS tissue from peripheral sites.

Main Methods:

• Utilizing mice overexpressing the Prnp gene (encoding the normal prion protein).
• Employing Prnp knockout mice.
• Conducting selective reconstitution experiments to express PrP in specific brain regions or hemato- and lymphopoietic cell populations.

Main Results:

• Demonstrated the utility of genetically modified mouse models for studying prion disease pathogenesis.
• Provided a framework for understanding how peripheral prion exposure leads to CNS infection.
• Offered insights into the molecular requirements for developing spongiform brain damage.

Conclusions:

• Transgenic and knockout mouse models are powerful tools for dissecting complex prion disease mechanisms.
• Pathogenesis can be clarified even without definitive knowledge of the prion agent's physical nature.
• These models facilitate understanding of prion neuroinvasion and the molecular basis of neurodegeneration.